Molecular Axiom

微哲默理

Molecular Axiom

Biotech/Healthcare

Molecular Axiom focuses on the discovery, clinical development, and commercialization of nucleic acid therapeutics. Its core capabilities span multiple RNA technology platforms, including ASO, RNAi, and mRNA, as well as drug delivery technologies such as LNPs.

Latest round: Series A (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-12-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.